+3.14% for IBM stock as Confluent acquisition boosts confidence

+3.14% for IBM stock as Confluent acquisition boosts confidence
IBM jumps 3.14% today to $238.00

International Business Machines Corporation (IBM) is trading at $238.00, which is below the MA-20 at $243.81, the MA-50 at $256.34, and the MA-200 at $276.42. This alignment signals bearish pressure across short-, medium-, and long-term timeframes, while the Ichimoku Kijun at $245.50 represents immediate resistance above the current price.

IBM price prediction
24H -0.15%
$271.82
48H -0.11%
$271.94
7D -0.26%
$271.54
1M 21.02%
$329.46
3M 14.73%
$312.33
6M 39.81%
$380.63
12M 6.53%
$290.03
Current price: $ 272.24 -2.6100 0.95%
Closed 06/12
Daily range 267.83 Arrow from to Icon 276.71
Weekly range 266.50 Arrow from to Icon 290.50
Loading...

Highlights

  • IBM and Arm announced a partnership to develop dual-architecture hardware targeting AI and data-intensive workloads.
  • IBM faces a $17 million settlement related to anti-discrimination claims and saw Alaska's state fund reduce its stake.
  • IBM trades below key moving averages with persistent bearish momentum; price expected to consolidate between $233.00 and $242.00.

Partnerships, settlements and stake reductions shift operational outlook

IBM has announced a partnership with Arm to develop dual-architecture hardware aimed at AI and data-intensive workloads. The company is also set to pay $17 million in a US settlement over claims related to anti-discrimination obligations required of federal contractors. IBM completed its acquisition of Confluent ahead of schedule and the State of Alaska Department of Revenue has reduced its investment position in the company.

Oversold levels clash with weak momentum amid volatile opening surge

Momentum remains weak, with both MACD and ADX signaling continued bearishness and little trend strength. RSI sits near oversold territory at 35.39, while CCI and Stoch RSI also read oversold; BBP confirms seller dominance intraday. Today’s price jumped at the open, creating an upward gap and moving the stock sharply higher, now trading near today’s range high with moderate volatility and sustained strength from the morning. However, the mix of oversold oscillators and continued momentum weakness highlights a divergence that tempers the conviction of today’s bullish thrust.

Limited upside as technical weakness narrows trading range outlook

For the next five trading days, IBM is expected to fluctuate between $233.00 and $242.00. The probability of a price increase is very low (less than 20%), while further downside is more likely given the persistent sell readings across D1 and W1 indicators. The baseline scenario is for prices to consolidate sideways within the current corridor. A bullish scenario would require a break above immediate resistance at $245.50, while a bearish outcome could unfold if support near $233.00 fails.

Anton Kharitonov, expert at Traders Union, notes that IBM remains under persistent bearish pressure, trading below all major moving averages despite a bullish morning gap. He sees weak momentum and multiple oversold indicators signaling that upside conviction is lacking, even as recent news flow introduces both partnerships and regulatory headwinds. The analyst expects continued consolidation within the $233.00–$242.00 corridor unless immediate resistance is reclaimed. "Base case remains sideways; until IBM breaks above $245.50, rallies are likely to fade."

Earlier, analysts noted that persistent bearish momentum and technical pressure were constraining IBM's share price. With ongoing weakness in momentum indicators despite corporate developments, traders should monitor for any decisive move above $245.50 resistance or a breakdown below $233.00 to signal the next directional shift.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.